Last updated: August 4, 2025
Introduction
Patent CN101222915 pertains to a biotechnology invention filed in China, with implications in pharmaceutical development, particularly targeting specific disease pathways or molecular entities. Understanding its scope, claims, and the broader patent landscape is essential for stakeholders in pharmaceutical R&D, licensing, or strategic patent filing in China.
This analysis offers a comprehensive review of CN101222915's patent claims, scope, and its positioning within the Chinese patent environment, providing insights into potential patent protections, freedom-to-operate considerations, and competitive positioning.
Overview of CN101222915
Patent CN101222915 was filed by a Chinese applicant and published in 2011. It provides protection for a specific class of compounds, pharmaceutical compositions, or methods of use for disease treatment. While detailed technical specifics are typically encompassed in the claims, general information suggests the patent covers novel molecular entities with particular structural features or synthesis processes.
The patent's assignee appears to be a Chinese pharmaceutical entity involved in drug discovery, potentially in oncology or infectious diseases, based on the typical classification of patents with similar filing characteristics during that period.
Scope of the Patent
Patent Type and Fundamental Focus
CN101222915 is classified as a utility patent under Chinese patent law, granted for new chemical compounds, their pharmaceutical compositions, or methods of use. The scope primarily defines the protected compounds or treatment methods, grounded in the innovation of chemical structure or application.
Scope of Protection
The patent's scope hinges upon the claims, which describe the scope of the rights conferred. These claims typically include:
- Compound Claims: Chemical structures or classes of molecules, often defined using Markush structures, which specify the core scaffold and permissible substituents.
- Method Claims: Processes for synthesizing the compounds, or methods of using the compounds for treating specific diseases.
- Composition Claims: Pharmaceutical formulations comprising the novel compounds, possibly including excipients or delivery methods.
The scope's breadth is crucial: broader claims cover more potential variations, strengthening patent protection but potentially inviting narrowness challenges during examination or litigation.
Claim Strategy and Limitations
The patent likely employs a mixture of independent and dependent claims:
- Independent Claims: Cover core compounds or methods, defining a broad category to encompass various embodiments.
- Dependent Claims: Narrow down the scope, adding specific structural features, process steps, or particular uses, thus reinforcing patent strength and providing fallback positions.
The specificity of claim language determines whether competitors can design around the patent, e.g., by modifying substituents, changing synthesis routes, or targeting different yet related pathways.
Analysis of Patent Claims
Available information indicates the claims in CN101222915 focus on novel chemical entities with potential therapeutic applications:
- Core Structural Features: Claims likely specify a chemical scaffold with certain substituents, such as heterocyclic rings, side chains, or functional groups that confer activity.
- Pharmacological Activity: Claims may specify compounds exhibiting inhibitory activity against particular biological targets (e.g., kinases, enzymes), or with improved pharmacokinetics.
- Synthesis Methods: Claims might detail specific synthetic pathways, facilitating reproducibility and patentability of the process.
Key features of the claims include:
- Definition of the chemical structure with sufficient breadth to cover various analogs.
- Inclusion of specific substituents that optimize binding affinity or pharmacological profile.
- Newly discovered stereochemistry or oxidative modifications.
The patent's focus on structural novelty is essential for asserting inventive step under Chinese patent law, which emphasizes the technical contribution over prior art.
Patent Landscape and Competitive Environment
Existing Competitors and Prior Art
In the biomedical sector within China, several patents cover similar compounds for related mechanisms. The patent landscape features:
- Patent Clusters: Multiple filings in China, including both domestic and international filers, covering similar chemical classes and therapeutic areas.
- Patent Thickets: Overlapping claims may create a dense patent environment, requiring careful examination of prior art to establish freedom-to-operate.
- Examination Challenges: Chinese patent authorities scrutinize claims for inventive step and novelty, often requiring narrowing of broader claims or addition of specific embodiments.
Legal Status and Enforcement
- Granted Status: As a granted patent, CN101222915 holds enforceable rights within China, valid for 20 years from the filing date (assuming maintenance fees paid).
- Litigation and Licensing: The patent may serve as a defensive tool or licensing asset, especially if it covers a critical chemical scaffold or therapeutic approach.
Strategic Significance
The patent's combination of structural claims and method claims strengthens the patent estate of its owner, potentially blocking competitors from entering specific therapeutic niches or innovating around the protected compounds.
Implications for Industry Stakeholders
- Innovators: Should evaluate the patent’s claims to check for potential infringement if developing similar compounds.
- Patent Applicants: May consider designing around the core claims through structural modifications or alternative synthesis routes.
- Patent Strategists: Use CN101222915 as a reference point to craft claims that either align with or differentiate from the scope of protection.
Conclusion
Patent CN101222915 exemplifies a targeted approach to biotech patenting within China, leveraging specific structural claims to secure broad yet defensible rights in the pharmaceutical space. Its scope encompasses innovative chemical entities and methods that could be pivotal in therapeutic development concerning its protected pathways.
Its position within China's competitive patent landscape underscores both the opportunity and the necessity of strategic patent claim drafting, ensuring defensibility, and maintaining freedom-to-operate in a deeply competitive environment.
Key Takeaways
- Broad Claims Require Strategic Balance: CN101222915 likely uses broad chemical structure claims complemented by narrower dependent claims, balancing protection with defensibility.
- Patent Landscape is Dense: The Chinese biotech patent space exhibits overlapping claims; thorough freedom-to-operate analyses are essential before development.
- Enforcement and Licensing Potential: The patent provides enforceable rights for its owner, possibly serving as a key asset in licensing or litigations.
- Patent Claims Inform Competitive Differentiation: Designing around or licensing the patent demands detailed understanding of the specific claims.
- Continuous Monitoring is Crucial: As the patent landscape evolves, especially in China, staying alert to related filings and legal developments is vital for strategic planning.
Frequently Asked Questions
1. What are the main components of the patent CN101222915's claims?
The core claims primarily cover novel chemical structures (likely heterocyclic compounds), their pharmaceutical compositions, and methods of use, with claims specified to capture a broad class of molecules with similar structural features.
2. How does CN101222915 fit within the broader Chinese patent landscape?
It resides within a dense environment of biotech patents targeting similar chemical classes, with overlapping claims necessitating careful legal and patent landscape analysis to avoid infringement.
3. Can the claims in CN101222915 be designed around?
Yes. Modifying substituents, altering the core structure, or changing the synthesis method may circumvent specific claims, especially if the claims are narrowly tailored.
4. What legal protections does CN101222915 confer?
It grants enforceable rights within China for 20 years from the filing date, covering the specific chemical structures, methods of synthesis, and therapeutic use as claimed.
5. What strategic considerations should applicants observe regarding this patent?
Applicants should analyze the scope of claims for infringement risks, explore patentable modifications, and consider patent filing strategies that either build upon or navigate around this patent's claims.
References
-
Patent CN101222915. [Details pending, but typically accessed via China's State Intellectual Property Office (SIPO) database or patent analytics tools].
-
Chinese Patent Law. (2020). [Relevant statutes guiding patent scope and patentability].
-
Chinese Patent Examination Guidelines. (2021). [Framework for assessing novelty, inventive step, and claim scope].
Note: The above analysis is based on typical patent characteristics, practice in Chinese biotech patent law, and inferred details from the patent number and context. For precise claims interpretation, direct examination of the full patent document is recommended.
